27-Mar-2012 - Eurofins Scientific, Inc.

Eurofins Enters Into an Agreement to Acquire QTA and a Supply Agreement with BASF

Eurofins Scientific, Inc. announces the planned acquisition of the Quality Trait Analysis (QTA®) business of BASF Corporation. The acquisition will strengthen Eurofins’  growing presence in the US while adding a unique business possessing the most advanced expertise in on-site quality analysis systems.

The QTA® System is a patented analytical service that enables clients to quickly and easily test the quality of products and materials, reliably and accurately. QTA® handles all the technical development, configuration, management and monitoring behind the scenes, enabling accurate quality testing by non-technical personnel, and allowing its clients more freedom in managing their operations. With high quality data, obtained in rapid times, QTA® helps its clients measurably increase the value of their finished product, improve process yields, reduce waste and rework, and improve profitability. Its leading technology serves global stakeholders in multiple industry segments, including biodiesel, pesticides, seed and grain, chemicals, food ingredients, and dietary supplements.

As an integral component of this deal, Eurofins also will enter into a supplier agreement with BASF Corporation to provide QTA® patented testing and technical support to BASF globally.

Facts, background information, dossiers
  • Eurofins
  • BASF
  • quality analysis
More about Eurofins Scientific
  • News

    Eurofins to acquire DNA Diagnostics Center

    Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (“DDC”), a leader in consumer genetic testing. DDC anticipates delivering revenues of over US$55m in 2021. DDC is one of the most hig ... more

    Eurofins expands presence in Discovery Pharmacology with the acquisition of Pan Labs US

    Eurofins Scientific, Inc. announced the signing of an agreement to acquire the Pan Labs pharmacology unit that was formerly operated by Ricerca Biosciences LLC and MDS Pharma.  Pan Labs is a provider in early stage discovery services with a portfolio that provides molecular pharmacology, fu ... more

More about BASF